UBS UBS · NYSE
$46.37 -1.07% (-$0.50)
Summary
48 / 100 · Bulios Score
What speaks for it
- Revenue grew by 17% a year over the last 3 years.
- The share price is below the Bulios Fair Price.
- It has raised its dividend 5 years in a row and pays out only 18% of profit.
What to watch
- Earnings per share fell by 6.0% a year over the last 3 years.
- Analysts expect revenue to fall by 9.4% this fiscal year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 15.1 USD for 1 USD of yearly profit. Over the last five years it was 13.9 USD on average.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 13% a year over 5 years. Over the last 3 years it grew by 17% a year. For the next fiscal year analysts expect revenue to fall by 9.4%. Earnings per share fell by 6.0% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 27 USD
- Sales and administration 56 USD
- Taxes and other 3.5 USD
- Net profit 14 USD
Net profit, industry median (Banks - Diversified) 18 USD
Out of every 100 USD of revenue, 14 USD is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 1.17%
- Paid out of profit
- 18%
- Raised in a row
- 5 years
You receive $0.55 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 16
- Hold 7
- Sell 6
Today's price within the analysts' price targets
The average target of $23.57 is 49% below today's price. 55% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
The company reports no revenue by product.
By region
- Americas 43%
- CH 38%
- Asia Pacific 19%
Americas brings in 43% of revenue. CH grew fastest, by 18% a year.
Segments in detail